A New England Journal of Medicine study published in 2021 found participants receiving GLP-1 drugs were more likely to show significant, sustained weight loss compared with those getting a placebo
In addition, expression of ARX (an cell-specific transcription factor) was upregulated, whereas that of CHGA (a marker gene for pancreatic endocrine cells) was unchanged (Supplementary information, Fig
A July 2024 Harvard study found diabetes patients prescribed semaglutide were over four times likely to develop NAION, while those prescribed it for weight loss were over seven times likely to develop this condition
If your semaglutide is truly red and this is different from what you normally receive, do not use it until you have confirmed with the pharmacy that the batch is correct
"What I'm taking, I'm not taking from anybody who needs the treatment." For Josephs, better health was the goal but 'looking good' is a bonus Josephs said that the number of people she knows who are taking injectable weight-loss drugs has become "endless." "Everyone is taking some version of something because everybody I know is running on all cylinders and has very high-powered jobs, or they're traveling nonstop and running around and want to lose a few pounds and have more energy," she said
Weight loss was discovered almost accidentally as a consequence of the biological mechanisms they engage, and understanding those mechanisms is essential for understanding why their effects extend so far beyond the scale